(-)-epigallocatechin 3-gallate multiple interactions ISO NFYB (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NFYB mRNA CTD PMID:22079256 (S)-nicotine decreases expression ISO NFYB (Homo sapiens) 6480464 Nicotine results in decreased expression of NFYB mRNA CTD PMID:18247414 1,2-dichloroethane decreases expression ISO Nfyb (Mus musculus) 6480464 ethylene dichloride results in decreased expression of NFYB mRNA CTD PMID:28189721 and PMID:28960355 1,2-dimethylhydrazine decreases expression ISO Nfyb (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of NFYB mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO Nfyb (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NFYB mRNA CTD PMID:17942748 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Nfyb (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Nfyb (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Nfyb (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of NFYB mRNA CTD PMID:21570461 and PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NFYB mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Nfyb (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of NFYB mRNA CTD PMID:16214954 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of NFYB mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NFYB mRNA CTD PMID:21215274 and PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Nfyb (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NFYB mRNA more ... CTD PMID:16214954 more ... 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of NFYB mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of NFYB mRNA CTD PMID:21346803 2-naphthylamine decreases expression ISO NFYB (Homo sapiens) 6480464 2-Naphthylamine results in decreased expression of NFYB mRNA CTD PMID:18247414 3,4-methylenedioxymethamphetamine increases methylation ISO Nfyb (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased methylation of NFYB promoter CTD PMID:26251327 3,4-methylenedioxymethamphetamine decreases expression ISO Nfyb (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of NFYB mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO NFYB (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NFYB mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of NFYB mRNA CTD PMID:19162173 4-hydroxyphenyl retinamide increases expression ISO Nfyb (Mus musculus) 6480464 Fenretinide results in increased expression of NFYB mRNA CTD PMID:28973697 5-fluorouracil affects expression ISO Nfyb (Mus musculus) 6480464 Fluorouracil affects the expression of NFYB mRNA CTD PMID:20421339 5-fluorouracil multiple interactions ISO NFYB (Homo sapiens) 6480464 Fluorouracil promotes the reaction [NFYB protein binds to UBE2C promoter] and TP53 protein mutant form affects the reaction [Fluorouracil promotes the reaction [NFYB protein binds to UBE2C promoter]] CTD PMID:27129209 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of NFYB mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO Nfyb (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of NFYB mRNA CTD PMID:19770486 aflatoxin M1 decreases expression ISO NFYB (Homo sapiens) 6480464 Aflatoxin M1 results in decreased expression of NFYB mRNA CTD PMID:30928695 all-trans-retinoic acid affects expression ISO Nfyb (Mus musculus) 6480464 Tretinoin affects the expression of NFYB mRNA CTD PMID:20421339 all-trans-retinoic acid decreases expression ISO NFYB (Homo sapiens) 6480464 Tretinoin results in decreased expression of NFYB mRNA CTD PMID:15498508 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NFYB mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO NFYB (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of NFYB mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO NFYB (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of NFYB mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO Nfyb (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of NFYB mRNA CTD PMID:23650126 arsenite(3-) multiple interactions ISO NFYB (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to NFYB mRNA] CTD PMID:32406909 benzo[a]pyrene decreases expression ISO NFYB (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of NFYB mRNA CTD PMID:18247414 benzo[a]pyrene increases methylation ISO NFYB (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of NFYB promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO Nfyb (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of NFYB mRNA CTD PMID:19770486 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of NFYB mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NFYB mRNA CTD PMID:34947998 bisphenol A decreases expression ISO NFYB (Homo sapiens) 6480464 bisphenol A results in decreased expression of NFYB mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO NFYB (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NFYB mRNA CTD PMID:28628672 carbon nanotube decreases expression ISO Nfyb (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 chlorpyrifos decreases expression ISO Nfyb (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of NFYB mRNA CTD PMID:37019170 choline multiple interactions ISO Nfyb (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NFYB mRNA CTD PMID:20938992 ciguatoxin CTX1B affects expression ISO Nfyb (Mus musculus) 6480464 Ciguatoxins affects the expression of NFYB mRNA CTD PMID:18353800 cisplatin multiple interactions ISO NFYB (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of NFYB mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO NFYB (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of NFYB mRNA CTD PMID:19376846 cocaine increases expression ISO NFYB (Homo sapiens) 6480464 Cocaine results in increased expression of NFYB mRNA CTD PMID:18000554 copper(II) sulfate increases expression ISO NFYB (Homo sapiens) 6480464 Copper Sulfate results in increased expression of NFYB mRNA CTD PMID:19549813 copper(II) sulfate decreases expression ISO NFYB (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of NFYB mRNA CTD PMID:19549813 Cuprizon affects expression EXP 6480464 Cuprizone affects the expression of NFYB mRNA CTD PMID:27523638 cyclosporin A decreases expression ISO NFYB (Homo sapiens) 6480464 Cyclosporine results in decreased expression of NFYB mRNA CTD PMID:20106945 more ... dexamethasone multiple interactions ISO NFYB (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NFYB mRNA CTD PMID:28628672 dibutyl phthalate decreases expression ISO Nfyb (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of NFYB mRNA CTD PMID:17361019 and PMID:21266533 dicrotophos decreases expression ISO NFYB (Homo sapiens) 6480464 dicrotophos results in decreased expression of NFYB mRNA CTD PMID:28302478 diquat increases expression ISO Nfyb (Mus musculus) 6480464 Diquat results in increased expression of NFYB protein CTD PMID:36851058 dorsomorphin multiple interactions ISO NFYB (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 ethanol affects expression ISO Nfyb (Mus musculus) 6480464 Ethanol affects the expression of NFYB mRNA CTD PMID:30319688 fluoranthene decreases expression ISO Nfyb (Mus musculus) 6480464 fluoranthene results in decreased expression of NFYB mRNA CTD PMID:28329830 folic acid multiple interactions ISO Nfyb (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NFYB mRNA CTD PMID:20938992 folic acid decreases expression ISO Nfyb (Mus musculus) 6480464 Folic Acid results in decreased expression of NFYB mRNA CTD PMID:25629700 geraniol decreases expression ISO NFYB (Homo sapiens) 6480464 geraniol results in decreased expression of NFYB mRNA CTD PMID:27683099 indometacin multiple interactions ISO NFYB (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NFYB mRNA CTD PMID:28628672 inulin multiple interactions ISO Nfyb (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NFYB mRNA CTD PMID:36331819 L-methionine multiple interactions ISO Nfyb (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NFYB mRNA CTD PMID:20938992 manganese atom decreases expression ISO NFYB (Homo sapiens) 6480464 Manganese results in decreased expression of NFYB mRNA CTD PMID:17175027 manganese(0) decreases expression ISO NFYB (Homo sapiens) 6480464 Manganese results in decreased expression of NFYB mRNA CTD PMID:17175027 manganese(II) chloride decreases expression ISO NFYB (Homo sapiens) 6480464 manganese chloride results in decreased expression of NFYB mRNA CTD PMID:17175027 methoxyacetic acid affects expression ISO Nfyb (Mus musculus) 6480464 methoxyacetic acid affects the expression of NFYB mRNA CTD PMID:20421339 methylmercury chloride decreases expression ISO NFYB (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of NFYB mRNA CTD PMID:28001369 methylparaben decreases expression ISO NFYB (Homo sapiens) 6480464 methylparaben results in decreased expression of NFYB mRNA CTD PMID:31745603 Monobutylphthalate affects expression ISO Nfyb (Mus musculus) 6480464 monobutyl phthalate affects the expression of NFYB mRNA CTD PMID:20421339 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO NFYB (Homo sapiens) 6480464 Methylnitronitrosoguanidine promotes the reaction [NFYB protein binds to RRM2 promoter] more ... CTD PMID:26921499 nicotine decreases expression ISO NFYB (Homo sapiens) 6480464 Nicotine results in decreased expression of NFYB mRNA CTD PMID:18247414 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NFYB mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of NFYB mRNA CTD PMID:25729387 paracetamol affects expression ISO Nfyb (Mus musculus) 6480464 Acetaminophen affects the expression of NFYB mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of NFYB mRNA CTD PMID:33387578 paracetamol increases expression ISO NFYB (Homo sapiens) 6480464 Acetaminophen results in increased expression of NFYB mRNA CTD PMID:21420995 paraquat decreases expression ISO NFYB (Homo sapiens) 6480464 Paraquat results in decreased expression of NFYB mRNA CTD PMID:35182771 PCB138 multiple interactions ISO Nfyb (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 pentachlorophenol increases expression ISO Nfyb (Mus musculus) 6480464 Pentachlorophenol results in increased expression of NFYB mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of NFYB mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid multiple interactions ISO Nfyb (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NFYB mRNA CTD PMID:36331819 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of NFYB mRNA CTD PMID:19162173 phenobarbital affects expression ISO Nfyb (Mus musculus) 6480464 Phenobarbital affects the expression of NFYB mRNA CTD PMID:23091169 phenobarbital affects expression ISO NFYB (Homo sapiens) 6480464 Phenobarbital affects the expression of NFYB mRNA CTD PMID:19159669 phenylmercury acetate decreases expression ISO NFYB (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of NFYB mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO NFYB (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NFYB mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO Nfyb (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NFYB mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO Nfyb (Mus musculus) 6480464 pirinixic acid results in decreased expression of NFYB mRNA CTD PMID:18445702 and PMID:20813756 potassium chromate decreases expression ISO NFYB (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of NFYB mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO NFYB (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NFYB mRNA CTD PMID:22079256 propiconazole decreases expression ISO Nfyb (Mus musculus) 6480464 propiconazole results in decreased expression of NFYB mRNA CTD PMID:21278054 rotenone increases expression ISO NFYB (Homo sapiens) 6480464 Rotenone results in increased expression of NFYB mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO NFYB (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Soman increases expression EXP 6480464 Soman results in increased expression of NFYB mRNA CTD PMID:19281266 sunitinib increases expression ISO NFYB (Homo sapiens) 6480464 Sunitinib results in increased expression of NFYB mRNA CTD PMID:31533062 tamibarotene decreases expression ISO NFYB (Homo sapiens) 6480464 tamibarotene results in decreased expression of NFYB mRNA CTD PMID:15498508 tert-butyl hydroperoxide decreases expression ISO NFYB (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of NFYB mRNA CTD PMID:15336504 thimerosal increases expression ISO NFYB (Homo sapiens) 6480464 Thimerosal results in increased expression of NFYB mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of NFYB mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NFYB mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of NFYB mRNA CTD PMID:25729387 trabectedin multiple interactions ISO Nfyb (Mus musculus) 6480464 trabectedin affects the activity of [NFYA protein binds to NFYB protein binds to NFYC protein] CTD PMID:15961672 trichostatin A decreases expression ISO NFYB (Homo sapiens) 6480464 trichostatin A results in decreased expression of NFYB mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO NFYB (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NFYB mRNA CTD PMID:27188386 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of NFYB mRNA CTD PMID:30589522 valproic acid affects expression ISO Nfyb (Mus musculus) 6480464 Valproic Acid affects the expression of NFYB mRNA CTD PMID:20421339 valproic acid affects expression ISO NFYB (Homo sapiens) 6480464 Valproic Acid affects the expression of NFYB mRNA CTD PMID:25979313 valproic acid decreases expression ISO NFYB (Homo sapiens) 6480464 Valproic Acid results in decreased expression of NFYB mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO NFYB (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NFYB mRNA CTD PMID:27188386